Fisetin
- Half-Life (t½)
- PO: 3.1h
- Formula
- C15H10O6
- Molecular Weight
- 286.24 g/mol
- Aliases
- 3,7,3′,4′-tetrahydroxyflavone
Pharmacological Mechanism
Flavonol with senolytic activity — preferentially induces apoptosis in senescent cells via Bcl-2/Bcl-xL inhibition. Also inhibits CD38 (NAD⁺ preservation), activates Nrf2 (antioxidant response), and reduces neuroinflammation (inhibits NF-κB and microglial activation). Strongest senolytic candidate among natural flavonoids in screens (Yousefzadeh 2018).
Half-Life & Elimination Curve (PO: 3.1h)
Plasma (PO)t½ Decay (3.1h)
- 0×t½0h100% (84.6 µg/L)
- 1×t½3.1h50% (42.3 µg/L)
- 2×t½6.2h25% (21.1 µg/L)
- 3×t½9.3h12.5% (10.6 µg/L)
- 4×t½12.4h6.3% (5.29 µg/L)
- 5×t½15.5h3.1% (2.64 µg/L)
Dosing Guidelines
- Oral (PO): Typical 233 mg (Range: 100–500 mg)
Pharmacokinetic Parameters
- Oral (PO): Bioavailability (F): 5% · Volume of Distribution (Vd): 84 L · Absorption (ka): 0.8 h⁻¹ (t½ka ≈ 52m) [PMID 21840301]
Pathways It Modulates
Target Organ Systems
- Musculoskeletal System
- Immune & Hematologic
Interactions
- Quercetin (synergistic): Both flavonols with overlapping senolytic and CD38-inhibitory activity.
Chemical Structure & Identifiers
- InChIKey: XHEFDIBZLJXQHF-UHFFFAOYSA-N
- SMILES: C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O
References